Clinical significance of detecting RNA and anti HEV antibody in convalesent sera in patients with acute HEV hepatitis / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
; (6): 268-271, 2004.
Article
em Zh
| WPRIM
| ID: wpr-279557
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the anti hepatitis E virus (HEV) and HEV RNA in acute and convalescent sera of patients with NonA-E acute hepatitis.</p><p><b>METHODS</b>The serum samples were taken from 95 patients who were diagnosed as acute NonA-E hepatitis. Enzyme immunoassay (EIA) was used for detecting anti-HEV Immunoglobulin G (IgG, Genolable and Wantai EIA anti-HEV kits). RT-PCR amplification of HEV RNA was based on the open reading frame 2 region of HEV and the PCR products were sequenced.</p><p><b>RESULTS</b>Sera from 95 patients who were negative for anti-HEV in acute phase were followed up for 11-35 days to detect the anti-HEV antibody in recovery phase, 16/95 (16.84%) were positive for anti-HEV (wantai EIA anti-HEV kits). Ten (62.50%) were positive for HEV RNA in acute phase. Sequence analysis showed that 4 were HEV genotype. 6 were HEV genotype; 12/95 (12.50%) were positive for anti-HEV (Genolable EIA anti-HEV kits). Seven were positive for HEV RNA; 4 belonged to HEV genotype, 3 were HEV genotype.</p><p><b>CONCLUSION</b>It is significant and necessary to detect anti HEV antibody and HEV RNA in patients with HEV infection during acute phase and convalesent phase.</p>
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Proteínas Virais
/
Virologia
/
Sangue
/
Imunoglobulina G
/
RNA Viral
/
Sequência de Bases
/
Anticorpos Anti-Hepatite
/
Convalescença
/
Doença Aguda
/
Sequência de Aminoácidos
Limite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Experimental and Clinical Virology
Ano de publicação:
2004
Tipo de documento:
Article
País de publicação:
CHINA
/
CN
/
REPUBLIC OF CHINA